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Preface  
Student role 
At the time of completion of part A of the project, I was employed as a Biostatistical 
Trainee at New South Wales (NSW) Department of Health and was placed at Hunter 
New England Population Health (HNEPH) in the Flutracking team. My task was to 
validate the Flutracking survey using time series analysis techniques, with assistance 
from my statistical supervisor (Dr Frank Tuyl), my content supervisor (Dr Craig Dalton) 
and co-supervisor (Mr David Muscatello).  
At the time of completion of part B of the project, I was employed by HNEPH to 
manage the Flutracking survey.  In conjunction with Dr Craig Dalton (my line manager 
at HNEPH), we devised a research question, based on an existing gap in knowledge 
for the Flutracking survey program: understanding factors affecting participant 
vaccination against influenza.  
For both parts of this project, I extracted multiple years of data from separate files, 
cleaned the data, and merged the data into a final data set. I also manipulated a 
number of variables in the dataset (such as adding a household identifier) to analyse 
the data accurately, and created a single symptom rate for each week of data. As there 
were no other colleagues at HNEPH with an understanding of the Flutracking dataset 
at this detailed level, this data preparation work was performed unassisted. 
For part A of this project I extracted laboratory notifications for influenza from the NSW 
Department of Health notifiable diseases database, using the Health Outcomes 
Statistical Toolkit (HOIST). Counts were aggregated into weeks based on the date of 
specimen collection. The extraction of laboratory notifications was performed with the 
assistance of Mr David Muscatello. 
My role also involved conducting all statistical analyses, with guidance from my 
statistical supervisors, Dr Frank Tuyl and Dr Patrick Kelly, and with assistance from my 
course notes from the Categorical Data Analysis (CDA) subject and Linear Models 
(LMR) subject. Guidance from my supervisors was based on my communication of the 
subject matter and data available to analyse. 
The value added to the Flutracking project was the finding that Flutracking data 
correlated as expected with laboratory data (providing reassurance that Flutracking is 
measuring influenza-like illness) and a better understanding of factors that affect 
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vaccination. The findings of a correlation with laboratory data were published in the 
journal of Communicable Diseases Intelligence, and I have presented these findings at 
The Public Health Association Australia (PHAA) annual conference in 2009 and at the 
NSW Department of Health Epidemiology Special Interest Group meeting in 2010. I 
also presented these results internally to HNEPH staff at the annual Population Health 
Symposium held in 2008. 
The information on factors affecting vaccination was presented to HNEPH staff at a 
staff meeting on 1 June 2010, and will be distributed to stakeholders of the survey, 
such as the Department of Health and Ageing, to better inform methods of promoting 
vaccination against influenza. 
Reflections on learning  
Communication skills 
Throughout this project I had face-to-face meetings with Dr Craig Dalton and Dr Frank 
Tuyl, and mostly corresponded by telephone meetings and email contact with Dr 
Patrick Kelly and Mr David Muscatello. Dr Kelly and Mr Muscatello did not have access 
to the dataset that was being analysed. Therefore, I learnt how to clearly communicate 
the subject matter relating to the dataset, the scope of the data, the data layout, the 
data limitations, and analytical findings already known from the dataset. In addition, I 
communicated my results and any issues I had in performing statistical analyses for the 
project. This process required communicating clearly and specifically (especially via 
email) to ensure my supervisors and I had the same understanding of the project and 
statistical results. In addition, my content supervisor (Dr Dalton) was based in Bhutan 
for part B of this project, and I was required to communicate the statistical methods 
used and results from these methods to this supervisor via email and telephone. The 
write up of the Workplace Project Portfolio (WPP) report also required similar 
communication skills. These communication exercises taught me how to clearly 
articulate data issues and statistical concepts and issues to an audience with detailed 
knowledge of statistical procedures, as well as an audience without statistical 
expertise. 
Work patterns/planning 
Completing a workplace project is a very different process than completing a 
coursework subject - coursework subjects are broken down into discrete modules with 
assessments due at pre-defined deadlines, whereas the WPP does not contain pre-
defined tasks due at set intervals (rather, one very large sometimes overwhelming 
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task), and therefore, required more discipline to ensure that the overall project would 
be completed on time. The WPP also differs, in that there is no guarantee that the 
planned statistical analysis will be appropriate, and that model checking may reveal 
additional analyses required to be performed. In addition, time must be allowed for 
feedback from multiple supervisors and revisions. I learnt to break down the WPP 
project into chunks (for example preparing data for analysis, performing statistical 
analyses, and writing different sections of the report) to submit to my supervisors at 
pre-defined times, as well as factoring time for feedback from multiple supervisors and 
revisions. 
Throughout this project I had regular meetings arranged in advance mutually by my 
statistical supervisors and myself. I always ensured that I called/arrived on time for 
each meeting. Before the end of each meeting I summarised what tasks I would have 
completed before the next meeting to ensure that I could meet task deadlines 
contributing to completion of the project on schedule.  
Statistical principles and methods 
This project provided several challenges in applying statistical principles. Part A of this 
project involved application of time series analysis techniques to autocorrelated data 
series – statistical techniques to control for autocorrelation had not been taught in any 
Biostatistics Collaboration of Australia (BCA) subject I have completed. Therefore, this 
provided a challenge beyond the scope of my Master of Biostatistics course. There 
were many challenges within the time series analysis component of the project. For 
example, we had originally planned to analyse 2007 and 2008 Flutracking and 
laboratory data. However, as Flutracking data were only collected from May to October 
for each of these years, understanding how autoregressive integrated moving average 
(ARIMA) analysis treated missing data (data between October 2007 and May 2008) 
provided a challenge. Also, other timeseries analysis techniques were explored such 
as fitting spline curves to the data, and so additional learning was required to 
understand the application of this to the dataset, and the advantages and 
disadvantages over ARIMA analysis.  
The original plan for part B of this project was to apply logistic regression techniques 
learnt in CDA to the Flutracking dataset. However, the nature of the dataset required 
intracluster correlation to be accounted for. I have not completed any BCA subjects that 
provide training on logistic regression modelling, controlling for intracluster correlation. 
Therefore, this project not only provided me with an opportunity to apply methods learnt 
in CDA, but also extended my knowledge of logistic regression modelling to the use of 
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a mixed effects logistic regression model, including how to specify and run this model 
in Stata, how to assess the fit of this type of model, and how to test model assumptions 
in this type of model. 
Another challenge in this project was to understand how the scope of the Flutracking 
data set might affect the statistical modelling results. For example, I learnt the impact 
that missing data can have on results, and the difficulties with quantifying this impact. 
Unvaccinated participants who did not complete all Flutracking surveys from October to 
December 2009 may have actually been vaccinated with Panvax after dropping out of 
the survey, and there may be some bias in the Panvax vaccination data. However, it is 
possible that the participants who dropped out of the survey early may be less 
concerned with influenza prevention, and therefore less likely to be vaccinated with 
Panvax than those participants who completed the final survey in 2009. With the data 
available, it was difficult to gain a further understanding of these possible effects. 
A further challenge was to apply model assumption testing to logistic regression, using 
my learnings from the LMR course. Assumption testing was not discussed in detail in 
the CDA course (and reference was made to refer to LMR notes), and I found some 
differences in the requirements for assumption testing between linear regression and 
logistic regression modelling. 
Statistical computing 
Data were cleaned using SAS version 9.1.3 and version 9.2, and statistical analyses 
were performed using SAS version 9.1.3 and version 9.2 and Stata version 10.0. In the 
BCA subjects, example data sets provided were generally in a layout that was ready to 
apply Stata commands. However, the Flutracking data required a significant amount of 
manipulation to achieve a format ready to apply commands for statistical modelling. For 
example, the original data set (once merged from multiple files) contained multiple 
survey records per participant. For the ARIMA analysis, this needed to be reduced to a 
single summary symptom rate for all participants for each week. For the logistic 
regression, the dataset needed to be reduced to a single record per person. These 
data manipulation processes were performed in SAS, and required application of some 
commands not previously taught in any BCA subjects (for example, ‘last.’). In addition, 
for the logistic regression analysis a cluster identification variable needed to be added 
to the dataset using an existing participant identifier and a variable specifying whether 
a participant was a respondent or a household member and who their primary 
respondent was. Although the SAS code used to create this identifier did not involve 
complex commands, it did require thought regarding the correct logic, and producing 
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several summary tables of final data to test the output produced. All data manipulations 
in SAS were performed without any guidance/advice. I solely relied on the resources of 
the ‘SAS help’ menu. 
For the statistical analyses performed in SAS and Stata, I learnt several new 
commands. For example, in SAS I learnt the ‘proc arima’ command used for time 
series analysis, and in Stata I learnt the ‘xtmelogit’ command used for mixed effects 
multilevel models and the ‘VCE’ option in the ‘logit’ command used for intraclass 
correlation. Performing logistic regression in Stata also reinforced the commands learnt 
in CDA, such as ‘logit’, ‘estat gof’, and ‘lrtest’. 
Team work  
Communication with other team members 
I worked with several other team members on this project: My statistical supervisors 
(Dr Patrick Kelly and Dr Frank Tuyl) and my content supervisors (Dr Craig Dalton and 
Mr David Muscatello). I met with each of these supervisors regularly (either by phone 
or in person), and liaised by email as required. As Dr Dalton was located overseas for 
part B of this project, most contact was via email. I arranged for a teleconference to 
occur between myself and my supervisors near the beginning of the project so that any 
differences in the understanding of the direction of the project could be discussed early 
on. Consequently, there were no communication issues identified throughout this 
process. 
Negotiating roles and responsibilities 
In initial face-to-face meetings between each supervisor and myself, the expectations 
of the project were discussed. We discussed modes of communication, analyses I 
would perform, and write up of the project. Therefore, roles were clear from the first 
meetings that I would be performing all analyses, with advice on statistical methods 
and feedback on all written drafts of the project to be provided by each of my 
supervisors. No issues were identified throughout the course of the project regarding 
roles.  
Working within timelines 
At the end of each meeting with my supervisors, I had set tasks to be completed prior 
to the next meeting. I always ensured that I completed the tasks that were assigned on 
time (or advised of any delays for completion of tasks), to ensure that the overall 
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deadline was met for completing the project. The WPP was submitted on time, 
demonstrating my ability to work within timelines.  
Helping others to understand statistical issues – teaching 
There were two scenarios in this project where I was required to communicate my 
findings to a non-statistical audience: 1) conveying results to my content supervisor, 
who is a public health physician. Despite not being a statistician, this supervisor has 
very good statistical knowledge, and so many concepts could be assumed. However, in 
communicating early findings from the project I ensured that I included a plain English 
description of results to reduce any confusion; 2) In communicating my findings to the 
public (for example, the journal of Communicable Diseases Intelligence, presentations 
of my findings to health professionals, the WPP report). This has required me to have a 
very clear understanding of the statistical techniques applied, so that I could convey a 
clear understanding for a non-statistical audience. 
Ethical considerations 
NHMRC ethics guidelines/confidentiality issues/professional 
responsibility 
The Flutracking project was approved by the Hunter New England Research 
Committee (06/04/22/4.03). All data collected up to 2 October 2009 were subject to 
ethics approval. After 2 October 2009, the Flutracking project was incorporated into 
routine national influenza surveillance. Therefore, it was no longer considered a 
research project and ethics approval was no longer required. Although most of the data 
used in the logistic regression project was not monitored by the ethics committee, I was 
still careful to protect the participants who consented to participate in the study and 
ensure that all results were reported objectively, consistent with the original aims of the 
Flutracking project.  
All data included in the analyses were stored on a secure password protected network 
within the HNEPH building. Only staff directly working on the Flutracking survey have 
access to this data. The data file containing participant details such as email 
addresses, usernames, age, and postcode of residence was purposely stored 
separately to the data file containing survey results. These two files were only linked 
via a common identifier variable. I was very careful when merging these two files, not to 
include irrelevant variables that might identify participants (such as email address and 
usernames). The resulting files that I produced for analyses only contained the 
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participant identifier variable and variables necessary for analysis. These data were 
only shown to my supervisors for the purposes of statistical advice. 
The results in this report were communicated carefully to provide objective findings. All 
assumptions and limitations associated with the data to the best of my knowledge were 
reported.  
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Cover page 
Project title 
FLUTRACKING SURVEILLANCE: A comparison of 2007 NSW symptom rates with 
laboratory confirmed influenza notifications and an examination of factors affecting 
community receipt of H1N109 vaccination. 
Location and dates 
This project used data from the Flutracking surveillance system (a joint initiative from 
Hunter New England Population Health and the University of Newcastle). Part A of this 
project was undertaken from February 2008 – January 2009 and part B of this project 
was undertaken from March 2010 - June 2010. 
Context 
This project explored an application of time series analysis techniques and logistic 
regression techniques to surveillance data on influenza-like illness. Part A of this 
project was conducted as a placement as part of the NSW Health Biostatistical Officer 
Training Program, and the research question was devised by Dr Craig Dalton. The 
statistical supervisor for Part A was Dr Frank Tuyl, and the content supervisors were Dr 
Craig Dalton and Mr David Muscatello. Part B of this project arose as a result of 
completing the Categorical Data Analysis (CDA) subject, and identifying analysis 
techniques from CDA that may be applied to particular research questions for the 
Flutracking data. The statistical supervisor for Part B was Dr Patrick Kelly, and the 
content supervisor was Dr Craig Dalton. The main objectives of parts A and B of the 
study were to: 1) to measure the correlation between Flutracking symptom rates and 
another reliable measure of influenza; and 2) understand the influence of participant 
characteristics on vaccination for H1N109 pandemic influenza. 
Student contribution 
 Identified the research question and type of statistical analysis to be applied for 
part B of the project, in conjunction with content supervisor 
 Prepared data for analysis, including data cleaning, merging multiple datasets, 
deriving applicable variables, and adding socio-economic status to the data 
 Conducted all statistical analyses 
 Prepared all manuscripts for submission 
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Statistical issues involved 
 Understanding and applying ARIMA time series analysis techniques 
 Identifying the type of regression model applicable to variables of analysis, and 
applying the logistic regression model 
 Understanding and checking the assumptions for ARIMA analysis and logistic 
regression 
 Adjusting for intraclass correlation 
Student declaration 
I declare this project is evidence of my own work, with direction and assistance 
provided by my project supervisors. This work has not been previously submitted for 
academic credit. 
....................................................... 
Sandra Carlson 
 
...................................................... 
Date 
Supervisors’ statements 
Dr Patrick Kelly: 
Sandra completed part A of this WPP while employed as a Biostatistical Trainee at 
NSW Department of Health. Although she was allowed to use this project as part of her 
WPP, it did not include a multivariable analysis, which is a requirement for a WPP. 
Hence, Sandra undertook a second analysis, which met this requirement (part B). Both 
parts of this project have involved analysing data from FLUTRACKING, but involve 
very different analyses. The work from both parts together is much more than what I 
would expect from a single WPP – I believe that part B is sufficient for a single WPP. 
However, since Sandra had already completed the work from part A, I agreed with 
Sandra that it was appropriate to include this as part of her WPP. 
Sandra has been a conscientious student who has worked independently and has 
been able to learn new statistical concepts quickly.  
 
....................................................... 
Dr Patrick Kelly 
 
...................................................... 
Date 
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Dr Frank Tuyl: 
As for Part A of this project, I can confirm that this is Sandra’s own work. Sandra did an 
excellent job of keeping this project on track, learning about ARIMA time series 
modelling etc, while developing, for example, an excellent framework to assist the 
week-to-week running of the Flutracking survey. 
 
....................................................... 
Dr Frank Tuyl 
 
...................................................... 
Date 
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Introduction   
The H1N109 influenza A virus that spread internationally in 2009 was a subtype of 
influenza that had not circulated previously in human beings. Therefore, the human 
immune system generally had little or no prior immunity, and it was possible that those 
who contracted the virus would experience more serious disease than that caused by 
normal seasonal influenza. In addition, transmission of this influenza subtype occurred 
globally. Therefore the H1N109 influenza A virus met criteria to be classified by the 
World Health Organisation as a ‘pandemic’1.   
In Australia, at a community level, a number of surveillance systems confirmed that the 
number of people infected with H1N109 was comparable to 2008, and not as high as 
2007 infection levels (for example, Australian Google Flu Trends data2 and data from 
the Australian Sentinel Practices Research Network).  Although H1N109 was a mild 
illness in most, in 2009 there were 4,992 people hospitalised (13% of confirmed cases) 
and 681 (14%) of these admitted to intensive care units3. There were 191 deaths due 
to H1N1093. The demographic characteristics of those seriously affected by H1N109 
were different to a normal influenza season, with younger age groups being more 
seriously affected, and the elderly being spared4. 
To prevent a second more virulent wave of the pandemic returning, and ensure 
protection of those most vulnerable to the disease, a new influenza vaccine (Panvax) 
was made available to the Australian population for free on 30 September 20095.  
The Flutracking surveillance system was the only Australian influenza surveillance 
system monitoring the uptake of the Panvax vaccine. Flutracking is a weekly online 
survey of influenza-like illness (ILI) completed by community members that integrates 
participants’ ILI symptom information with their influenza vaccination status.  The 
Flutracking surveillance system collects information on symptoms of fever, cough, and 
absence from work or normal duties due to fever or cough. In addition, Flutracking 
captures information on participant age, postcode of residence, whether or not the 
participant works face-to-face with patients, and seasonal influenza vaccination status. 
Flutracking aims to help fill the gap between laboratory and syndromal surveillance 
systems because it uniquely combines information on influenza symptom rates and 
vaccination status of participants. In 2009, as soon as the Panvax influenza vaccine 
was released, Flutracking began monitoring of the uptake of this vaccine in 
participants.  
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The purpose of part A of this study was to use time series methods to validate 
Flutracking as a method of influenza surveillance, through comparison of 2007 New 
South Wales (NSW) Flutracking data with NSW data for laboratory confirmed influenza. 
It is acknowledged that while laboratory confirmed influenza surveillance data may be 
biased by testing activity, it is usually considered the most reliable indicator of the onset 
and peak of influenza activity. Therefore, laboratory data are often used as the default 
measure for comparing the performance of syndromal (or 'syndromic') influenza 
surveillance. Zheng et al compared emergency department visits assigned a clinical 
diagnosis of influenza to NSW influenza laboratory data to determine whether the 
former could offer earlier warning of an increase in influenza incidence in the NSW 
population6. Lau et al defined the start of peak influenza activity using laboratory 
isolation rates for their analysis of multiple streams of influenza surveillance data7.  
The purpose of part B of this study was to use Flutracking data to investigate the 
relationship between receipt of the vaccination for H1N109 Pandemic influenza 
(vaccination with Panvax) and receipt of the seasonal influenza vaccination, as well as 
other demographic influences on receipt of the Panvax vaccination. 
Part A of this study has been accepted and published in the journal of Communicable 
Diseases Intelligence8. An expanded methods section is included in the current report. 
The results and discussion sections were directly obtained from the published report. 
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PART A:  Validating Flutracking as a method of 
influenza surveillance 
Flutracking recruitment and data collection  
A number of different methods were used to recruit participants for the Flutracking 
survey. An invitation to participate in the online survey was sent to approximately 7,000 
email addresses on the Hunter New England area health service network with a 
clickable link to the survey. There was a national media release sent to all major 
newspapers and radio stations.  A short domain name (www.flutracking.net) was used 
to assist the memory of people hearing or reading the recruitment messages. Emails 
were sent to colleagues and friends of investigators and participants were able to 
forward the invitation email on to acquaintances to consider joining the study. Potential 
participants were directed to a web page providing information about the study and an 
online consent form. A confirmatory email response from the participant's email 
address was required to complete enrolment in the study.  
The study was approved by the Hunter New England Area Health Service Human 
Research Ethics Committee. Participants were allowed to join (or exit) at any time 
during the surveillance period. Further information on recruitment methods can be 
obtained from Dalton et al9. 
Each Monday during the typical influenza season (May/June to October each year), 
participants received an automatically generated weekly email link to the online survey. 
In the first online survey participants were asked about their usual postcode of 
residence; whether they work face-to-face with patients in hospitals, nursing homes, 
doctors' surgeries or as community health workers; their month and year of birth; and 
whether they received an influenza vaccination in the previous or current year.  
For each subsequent survey, participants were asked whether during the prior week 
(ending Sunday) they had experienced fever and/or cough and/or muscle aches on any 
specific day/s, and whether they had been absent from usual activities on any specific 
day/s. Participants who reported not being vaccinated against influenza in the current 
season were asked if they had received vaccination in the prior week during each 
weekly survey. If they responded in the affirmative the question was automatically 
deleted from their subsequent weekly surveys, and their status was updated to 
‘vaccinated’ for all following weeks.  
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Methods 
At the time of analysis, data were available for 2006 – 2008. However, data from 2006 
were pilot data, and there were too few participants to include in the time series 
analyses (394 participants completed one or more surveys). Data from 2008 were 
considered for analysis, however missing data between October 2007 and April 2008 
posed difficulties for ARIMA analysis. Therefore, NSW data for 2007 only (for the week 
ending 3 June 2007 to the week ending 14 October 2007) were included in the 
analysis. NSW data accounted for 76% of all participants in Australia who completed at 
least one survey during 2007. For the purpose of this analysis, the laboratory data was 
classified as the independent variable, and each of the Flutracking symptoms were 
classified as dependent variables.  
For each of the vaccinated and unvaccinated groups, a time series of the proportion of 
respondents reporting any of five possible case definitions was created. The case 
definitions were:  
 fever only;  
 cough only;  
 absence from work or normal duties;  
 fever and cough; or  
 fever, cough and absence from work or normal duties.  
A time series of weekly counts of positive influenza antigen tests (polymerase chain 
reaction and direct immunofluorescence) were created from the NSW Department of 
Health notifiable diseases database10. Unit record data were extracted from the Health 
Outcomes Statistical Toolkit (HOIST).  Counts were aggregated into weeks based on 
the date of specimen collection.  
We used autoregressive integrated moving average (ARIMA) time series analysis 
techniques and cross correlation analysis to determine whether there was an 
association between the laboratory time series and weekly proportions for each 
Flutracking case definition. The ARIMA method was chosen because, in time series 
modelling, the assumption that model residuals are independent is typically violated 
due to the residuals being autocorrelated (i.e. the current values of a series correlate 
with past values of the same series)11. If autocorrelation is not removed, then the 
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relationship between two time series could be overestimated12. Any comparisons made 
between laboratory data and Flutracking data potentially require correction for 
autocorrelation. ARIMA modelling is a well established time series analysis technique 
that can be used to model an autocorrelated variable11. Adding an independent 
variable to the usual ARIMA model (called transfer function analysis)13 allows the 
relationship between two time series to be measured, while correcting for 
autocorrelation. 
As the Flutracking data used for analysis were proportions, the variance stabilising 
transformation for binomial data was applied14. This is an arcsine transformation, Ya = 
arcsin sqrt(Y), where Ya is the transformed Flutracking data, and Y is the proportion of 
participants with the particular Flutracking symptom/s specified by each case definition. 
Similarly, the laboratory data were counts, and the variance stabilising transformation 
for a Poisson distribution was applied: Xa = sqrt(X) where X is the original laboratory 
data, and Xa is the transformed laboratory data
14.  
For the vaccinated and unvaccinated groups, we calculated raw correlations with the 
laboratory notifications. These estimates were produced to compare to the estimates 
with autocorrelation controlled for, to determine whether there was a difference in 
results. We then used ARIMA models to estimate the association between weekly 
proportions of respondents reporting each case definition and weekly counts of positive 
influenza isolates. The SAS ARIMA15 procedure was used to compute cross 
correlations between the two data series at various time differences, after both series 
had been 'prewhitened' (that is, filtered by an ARIMA model that was originally fitted to 
the independent variable).  
Results  
Descriptive statistics  
In NSW, for the 20 week period between 3 June and 14 October 2007, there was an 
average of 502 participants per week who completed the survey. Over that period, a 
weekly average of 65% of participants reported being vaccinated.  
Visual inspection of the time series of each Flutracking case definition against 
laboratory data suggested that the peaks in laboratory data corresponded to periods of 
high Flutracking symptom rates for the unvaccinated group compared with the 
vaccinated group. A graph for the 'fever and cough' case definition is shown in Figure 
1.  
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Figure 1: Flutracking symptom rates for 'fever and cough' case definition, compared 
with influenza laboratory notification counts, NSW, 2007, by influenza vaccination 
status.  
 
Raw correlation analysis  
Using raw correlation analysis (i.e. without autocorrelation correction), we found that 
the correlation values were generally highest when Flutracking symptom rates and 
laboratory data were compared in the same week (i.e. a lag of zero), but similar values 
also occurred at other differences in time (or lags).  
Each Flutracking case definition in both the vaccinated and unvaccinated groups 
showed a statistically significant relationship with the laboratory data at a lag of zero 
(all P values for the correlation coefficients were less than 0.05). However, it was 
important to further analyse the relationship between the two time series using ARIMA 
analysis.  
Autoregressive integrated moving average analysis  
Results from an autocorrelation check for white noise using ARIMA analysis indicated 
that laboratory data showed significant autocorrelation (at the level of P = 0.05), and 
that the model that fitted this data best was Yt = 1.6 Yt–1 – 0.6 Yt–2 + et where Yt is the 
laboratory data at time t (in weeks), and e are the residuals from the model. This model 
was used to pre-whiten both the Flutracking and laboratory data.  
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Cross correlations for the residuals from the ARIMA model applied to the laboratory 
data and each of the Flutracking data series are summarised in Table 1. Only cross 
correlation values at a lag of zero for each case definition related to laboratory data are 
reported.  
Table 1: Cross correlation and corresponding probability values from the ARIMA 
analysis for each Flutracking case definition symptom rate compared with influenza 
laboratory notifications, NSW, 2007, by vaccination status.  
Vaccination 
status 
Case definition 
Cross 
correlation value 
Probability value for cross correlation 
(using a one-tailed t statistic) 
Vaccinated Fever –0.006 1 
Vaccinated Cough 0.302 0.097 
Vaccinated Absence –0.054 1 
Vaccinated Fever and cough 0.203 0.188 
Vaccinated 
Fever, cough and 
absence 
–0.072 1 
Unvaccinated Fever 0.654 0.005 
Unvaccinated Cough 0.623 0.006 
Unvaccinated Absence 0.442 0.032 
Unvaccinated Fever and cough 0.640 0.005 
Unvaccinated 
Fever, cough and 
absence 
0.652 0.005 
In the unvaccinated group, all cross correlations at a lag of zero weeks were 
statistically significant at a level of P = 0.05. The cross correlation analysis did not 
provide evidence of a substantive difference between the case definitions, except for 
'absence from work or normal activities,' which at 0.442, did not have as high a cross 
correlation as the other symptoms. In the vaccinated group no case definitions at a lag 
of zero were statistically significant at a level of P = 0.05. The results from the ARIMA 
analysis for the vaccinated group were not consistent with results from raw correlation 
analysis, where there were statistically significant relationships between every case 
definition for the vaccinated group and the laboratory data.  
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Discussion  
There was a statistically significant correlation between time series of laboratory 
confirmed influenza and Flutracking data for unvaccinated participants in NSW for all 
five case definitions (fever; cough; absence; fever and cough; fever, cough and 
absence) at a lag of zero weeks. This indicates that Flutracking responds 
contemporaneously with laboratory surveillance of disease caused by influenza that 
leads to a specimen being collected. For the vaccinated group who should have at 
least some protection against influenza infection, cross correlations were not 
statistically significant after correction for autocorrelation, indicating that Flutracking can 
discriminate between influenza and other causes of ILI disease.  
For vaccinated participants, the change in statistical significance between raw 
correlation results and ARIMA modelling results demonstrates the importance of 
adjusting for autocorrelation, and using appropriate analysis techniques for time series 
data. Without controlling for autocorrelation, spurious results were obtained. However, 
after correcting for autocorrelation the 'true' relationship between the two data series 
could be seen.  
A limitation when quantifying the relationship between the Flutracking and laboratory 
data was that there were only 20 continuous time points in the weekly Flutracking data 
series, when usually at least double that number are recommended for ARIMA 
analysis11. However, we confirmed by Monte Carlo simulation that a model of the type 
found for the laboratory data, nearly always generates data that are clearly 
autocorrelated, even when there are only 20 time points, based on checking by time 
series analysis.  
In conclusion, this analysis of Flutracking results has provided support for its value in 
providing alerts of influenza activity. Distinguishing between vaccinated and 
unvaccinated participants offers further potential to determine the value of Flutracking 
in assessing the effectiveness of the annual influenza vaccine composition in real-time.  
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 PART B: Factors associated with H1N109 vaccination 
Data 
Data were obtained from Hunter New England Population Health. The primary dataset 
used was October - December 2009 national Flutracking data. Only data from October 
onwards were included for analysis as this is when the Panvax vaccine was made 
publicly available to persons 10 years of age and over. The Panvax vaccine was made 
available to children 6 months to 9 years of age on 3 December 200916. Due to the late 
availability of the vaccine to children under the age of 10 years, the data included for 
analysis in part B were restricted to participants 10 years of age or older. 
In addition to the 2009 Flutracking data, the 2007 and 2008 datasets were also 
accessed to obtain data on years of participation in the Flutracking survey for those 
who participated from October to December 2009. Table 2 shows the relevant 
variables from the 2009 Flutracking data files. Note that not all variables are listed from 
each of the 2009 data files – only those relevant to the analysis are listed. 
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Table 2. Variables used for analysis from Flutracking 2009 data. 
Variables used Format Description 
Participant file (.xls file) 
ParticipantID Numeric (up to 
4 digits) 
Unique identifier for each participant in the survey 
(retained over each year of participation) 
BirthMonth Numeric (mm) Month participant was born 
BirthYear Numeric (yyyy) Year participant was born 
Postcode Numeric(4 digit) Postcode of residence of participant 
WorkWithPatients Numeric (1,2,3) Whether participant works face-to-face with patients (1 = 
yes, 2 = no, 3 = don't know) 
MasterRecordID Numeric (up to 
4 digits) 
Identifier for whether participant responded for 
themselves or on behalf of other household members (0 
recorded if responding for self, otherwise ParticipantID 
of the person responding on behalf of household 
member is recorded) 
Survey file (.xls file) 
ParticipantID Numeric (up to 
4 digits) 
Unique identifier for each participant in the survey 
(retained over each year of participation) 
H1N1 Numeric (1,2,3) Whether received Panvax (H1N109 vaccination) (1 = 
yes, 2 = no, 3 = don't know) 
SurveyWeek Numeric 
(ddmmyyyy) 
Week beginning date for survey reference period - this 
was not in date format 
Seasonal vaccination file (.xls file) 
ParticipantID Numeric (up to 
4 digits) 
Unique identifier for each participant in the survey 
(retained over each year of participation) 
VaccinationYear Numeric (yyyy) Year of vaccination with seasonal influenza vaccine 
Vaccinated Numeric (1,2,3) Whether received seasonal influenza vaccination (1 = 
yes, 2 = no, 3 = don't know) 
RecordEntryDate Date time 
(dd/mm/yyyy 
hh:mm) 
Date participant changed vaccination status - 
participants could change vaccination status throughout 
the year, therefore multiple records existed in this file 
per participant and year)  
The procedure for obtaining the Flutracking data to analyse in part B follows:  
1) The participant, survey and vaccination files were imported into SAS version 
9.2. Data files were checked for duplicate records to ensure that there was a 
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unique record for each participant identification number and survey week. There 
were no duplicate records identified. 
2) An age variable was created on the participant file using the formula: =2009 
minus year of birth. There was one participant with an implausible age value of 
2009 – this record was deleted from the file. 
3) The three data files (Participant file, Surveyfile, and Seasonal vaccination file) 
were merged in SAS (by Participant ID) to create one file with ParticipantID and 
SurveyWeek as the unique identifiers. Each participant had multiple records – 
one record for each survey completed from October to December 2009. 
4) Participants with a seasonal vaccination status or Panvax (H1N109) vaccination 
status of ‘don’t know’ were excluded from the data. 
5) SurveyWeek was converted from week beginning to week ending and to a date 
format (dd/mm/yy) to allow the last survey completed per participant to be easily 
identified and retained. 
6) This data file was appended to Flutracking 2007 and 2008 data files (the 2007 
and 2008 data files were prepared in a similar manner to the 2009 data – 
however some variables were not available on 2007 and 2008 datafiles). As the 
SAS procedure to append data requires variable names to be consistent on all 
files, some adjustments were required to the 2007 and 2008 files: 1) Dummy 
variables were created for Panvax vaccination status and MasterRecordID 
(MasterRecordID was only unavailable in 2007). In addition, a variable ‘Year’ 
was created to indicate year of survey completion, and finally, a variable for 
years of participation was created. This required data manipulation, including 
the use of the ‘proc transpose’ procedure to obtain a new dataset with this 
variable, and then remerging this new dataset with the original dataset. 
7) After a file was created containing all three years of data, records without a 
value for Panvax vaccination status were excluded (only records from October 
2009 to December 2009 were included), and only the last survey per participant 
within this timeframe was kept (therefore, there was only one record per 
participant, as opposed to one record per participant and survey week). 
8) Records for participants under the age of 10 years were excluded from the file. 
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9)  Socio-economic status (SES) scores were added to the file. These scores were 
obtained from the Australian Bureau of Statistics website17. The index of relative 
socio-economic advantage and disadvantage was used to assess socio-
economic status in the current analysis. In this index a lower score indicates 
that an area is relatively disadvantaged compared to an area with a higher 
score. The index for advantage and disadvantage was used rather than the 
index of disadvantage only because vaccination with Panvax was expected to 
be affected by both advantage and disadvantage.  
 
As the difference between scores may not be equal (for example the difference 
in disadvantage between scores of 500 and 600 is not equal to the difference 
between scores of 900 and 1000) this variable could not be used as a 
continuous variable in regression analysis. Therefore, it was decided to use 
quintile categories for analysis. Postal areas were ordered from lowest to 
highest score (a low score indicating the postal area was relatively 
disadvantaged compared to an area with a high score). Quintiles were formed 
from these scores with the lowest 20% of postal areas given a code of 1, and so 
on up to the highest 20% of postal areas given a code of 5. 
 
The index of relative socio-economic advantage and disadvantage for postal 
areas was imported into SAS as a .csv file and merged (by postcode) with the 
data file.  
10)  The MasterRecordID variable was used to create a unique household identifier, 
as well as a variable for the number of participants per household. This was 
necessary to adjust for any intraclass correlation for groups of participants in 
each household. Failure to adjust for any intraclass correlation, could 
underestimate standard errors in regression analysis, and therefore artificially 
overestimate any relationships found. 
11)  Non-essential variables were removed from the final file. All variables in the 
final file that were used in analyses are described in Table 3.  
12) The final file was then exported as a .csv file, and this .csv file was imported 
into Stata 10.0 for further analysis. Stata was used for all regression analysis as 
this was the software package practiced most during the Master of Biostatistics 
course. 
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13)  A check was performed of potential bias due to missing data for participants 
who were vaccinated with Panvax after dropping out of the survey. There were 
2453 participants who dropped out of the survey prior to the last week of 
participation. Of these participants 1977 (80.6%) were not yet vaccinated with 
Panvax. It is possible that some of these participants may have actually been 
vaccinated with Panvax after dropping out of the survey, and there may be 
some bias in the data. However, it is possible that the participants who dropped 
out of the survey early may be less concerned with influenza prevention, and 
therefore less likely to be vaccinated with Panvax than those participants who 
completed the final survey in 2009. 
Table 3. Variables in final data file for analysis. 
Variable Description 
ParticipantID Unique identifier for each participant 
Yrspart Number of years participated in the survey (ranges from 1 to 3) 
WorkWithPatients Whether participant works face-to-face with patients (1 = yes, 2 = no, 3 
= don't know) 
Age Participant age in years  
H1N1 Whether received Panvax vaccination (1 = yes, 2 = no) 
Vax09 Whether received seasonal influenza vaccination (1 = yes, 2 = no) 
Score_adv_disadv Socio-economic status score  
Ses_quintile Socio-economic status quintile  
Hhid Unique identified for each household 
hhmember Whether participant responded for themselves (primary respondent) or 
had another household member respond on their behalf (other 
respondent) (1 = other respondent and 0 = primary respondent) 
Cluster Number of participants per household 
Weekending week that last survey of 2009 was completed (dd/mm/yy) 
Methods 
The relationship between Panvax vaccination status and the covariates: seasonal 
vaccination status; whether works face-to-face with patients; age; socio-economic 
status; and number of years participated in the survey was assessed using binary 
logistic regression.  Binary logistic regression was chosen because the explanatory 
variable (Panvax vaccination status) had values of 0 and 1 only, and so followed a 
binary distribution. From the Categorical Data Analysis (CDA) subject, binary logistic 
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regression is suitable, widely used, and easy to implement in common statistical 
packages such as SAS and Stata.  
The logistic regression model is a type of generalised linear model that relates a linear 
regression model to a response/dependent variable via the logit link function 
(     ( )    (
 
   
)). Binary logistic regression is used when the outcome variable is 
dichotomous. The equation used to describe binary logistic regression is:      ( )  
  (
 
   
)                . The independent variables in the model can be 
continuous or categorical.  
The dependent variable in the binary logistic regression model for the current analysis 
was Panvax vaccination status (H1N1). The independent variables were: Years of 
participation (yrspart); whether participant worked face-to-face with patients 
(workwithpatients); age (age); seasonal vaccination status (vax09); and socio-
economic status quintile (ses_quintile).  
All independent variables were categorical variables, except for age. To allow easy 
interpretation of results, age was categorised into five groups: 10-19 years, 20-34 
years, 35-49 years, 50-64 years, and 65 years and over. These categories were 
chosen based on ages more or less likely to get immunised against influenza. 
The equation used to describe the logistic regression model was:      ( )    (
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where:  
the outcome variable (H1N1 vaccination status) has two categories 
p is the probability of being vaccinated with Panvax 
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Before fitting the multivariate logistic regression model, univariate statistics were 
produced for each individual covariate as well as the dependent variable (Panvax 
vaccination status). The purpose of the univariate analyses was to describe the data.  
Tables of counts of participants in each covariate category were produced, as well as 
the percentage of participants vaccinated with Panvax in each covariate category.  
Univariate logistic regression analyses were performed to show the relationship 
between each covariate and the dependent variable (vaccination with Panvax). 
However, measuring relationships between independent and dependent variables in 
univariate analysis cannot control for the effects of other covariates, or provide any 
information on the relationships between covariates. Therefore, multivariate logistic 
regression analysis was also performed.  
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In the Flutracking survey a participant can respond on behalf of other household 
members, therefore there may be potential positive correlation between observations 
from the same household. This correlation needs to be taken into account in order to 
obtain correct variances of regression coefficients18 and avoid incorrect statistical 
inferences. In the current analysis, this was achieved by empirically adjusting the 
standard errors using the sandwich estimator in the logistic regression models. This 
was achieved using the Stata option ‘VCE(cluster variable)’ for the ‘logit’ command.  
The goodness of fit of the model was assessed overall. The Hosmer Lemeshow test for 
goodness of fit was chosen because it has the advantage over the chi squared 
goodness of fit test of being able to split observations into groups of approximately 
equal size, so there are less likely to be groups with low observed and expected 
frequencies19.   
The following assumptions for the final logistic regression model were also checked: 
1) The outcome variable (Panvax vaccination status) was checked to ensure it was 
linearly related to the log odds of the combination of the dependent variables.  
2) Outliers/influential observations were assessed. 
3) Multicollinearity between covariates was assessed (covariates should be 
independent from one another). Multicollinearity occurs when two or more variables in 
the model are approximately equivalent to a linear combination of other variables in the 
model (from LMR course notes). When there is perfect collinearity, Stata notifies this in 
the model. To measure less severe multicollinearity, the Stata command ‘collin’ was 
used. The VIF (variance inflation factor) was used to assess the level of 
multicollinearity in the model.  
Results  
Descriptive statistics 
There were 7145 participants greater than or equal to 10 years of age who completed 
at least one Flutracking survey in 2009 and responded to the survey question asking 
about Panvax vaccination status. Table 4 provides summary statistics for these 
participants.   
31 
 
Table 4 shows that just over one third of participants (33.1%) were vaccinated against 
H1N109. Of those participants who were vaccinated against H1N109, 82.1% were 
vaccinated in either October or November.   
More than half of participants were vaccinated with the seasonal vaccine (60.9%) and, 
of these participants, almost half (47.0%) were vaccinated against H1N09. Whereas 
only 11.4% of those who did not receive the seasonal vaccine, received the Panvax 
vaccine.  
There were 49.0% of participants who participated in Flutracking for more than one 
year (completed at least one survey in 2009, as well as either 2007, 2008 or both 
years). As the number of years of participation increased, the percent of participants 
vaccinated with Panvax also increased (from 30.5% to 40.6%).  
As age increased, the percent of participants vaccinated with Panvax also increased 
from 12.7% in the 10-19 years group to 55.2% in the 65 years and over age group.  
There were 27.6% of participants who worked face-to-face with patients. Of these 
participants, less than half (44.3%) were vaccinated against H1N109. However, the 
percent of participants vaccinated against H1N109 was higher in this group than those 
who did not work face-to-face with patients (28.7%).  
The number of participants in each socio-economic status quintile increased for each 
increase in quintile. However, there did not appear to be any difference in vaccination 
uptake between socio-economic status quintiles, with approximately one third of 
participants being vaccinated in each quintile. 
More than two thirds of participants (73.4%) were primary respondents (participants 
who responded for themselves, and may or may not have responded for other 
participants in their household). There was a higher proportion of primary respondents 
vaccinated against H1N109 (37.4%), as compared to other household members in the 
survey (21.2%). However, the average age of a primary respondent was 46.4 years 
(s.d. = 11.4) and the average age of other household members was 36.5 years (s.d. = 
19.0). Therefore, this higher vaccination uptake rate may be confounded by age. 
Just under half of participants (44.8%) had more than one respondent per household. 
As household size for participation increased (from 1 to 8), percent vaccinated against 
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H1N109 generally decreased. However, this result may also be confounded by age – in 
general, age decreased as size of household increased (see Figure 2). 
Most participants last completed a survey in December 2009 (80.2%).  
Table 4. Description of participant characteristics, Flutracking data, Australia, October – 
December 2009. 
Variable Categories  Total 
 
Number 
vaccinated with 
Panvax 
% 
vaccinated with 
Panvax 
Overall N/A 7145 2363 33.1 
Seasonal vaccination 
status 
Vaccinated 4349 2044  47.0 
Unvaccinated 2796 319  11.4 
Years of participation 1 3642  1109 30.5 
2 2910 1013 34.8 
3 593  241  40.6 
Age (years) 
  
  
10 – 19 584 74 12.7 
20 – 34 1214 333 27.4 
35 – 49  2496 795 31.9 
50 – 64  2534 986 38.9 
65+ 317 175 55.2 
Working face-to-face 
with patients 
Yes 1974 875 44.3 
No  5149 1480 28.7 
Don’t know 22  8  36.4 
Socio-economic 
status 
Quintile 1 
(lowest quintile) 
632 227 35.9 
 Quintile 2 838 277 33.1 
 Quintile 3 1557 529 34.0 
 Quintile 4 1888 621 32.9 
 Quintile 5 
(highest quintile) 
2230 709 31.8 
 NA=Not Applicable 
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Figure 2. Average age in years (and standard deviation) for each household size. 
 
Logistic regression  
 All variables included in the univariate and multivariable logistic regression analyses 
were classified as categorical variables. Table 5 shows the results from the univariate 
logistic regression models and Table 6 shows the results from the multivariate model. 
Both tables show the standard errors, unadjusted and adjusted for clustering within 
household. As expected, the adjusted standard errors are slightly larger.  
Table 5 shows that (without controlling for any other covariates) having the seasonal 
influenza vaccine was strongly related to receiving the Panvax vaccine, with the odds 
of receiving the Panvax vaccine increasing by 589% for those who received the 
seasonal vaccine, as compared to those who did not.   
The number of years a participant participated in the survey also showed a statistically 
significant relationship (p < 0.001) with uptake of the Panvax vaccine (without 
controlling for any other covariates). For each increase in the number of years 
participating in the Flutracking survey, the odds of receiving the Panvax vaccine 
increased.  
Age of participants was also strongly related to receiving the Panvax vaccine. For each 
increase in age group, the odds of receiving the Panvax vaccine increased (without 
controlling for any other covariates). In particular, the odds of receiving the Panvax 
vaccine increasing by 749% for those participants aged 65 years and over compared to 
those in the 10-19 years age group.  
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Working face-to-face with patients was also strongly related to receiving the Panvax 
vaccine, with the odds of receiving the vaccine increasing by 97% for those who 
worked face-to-face with patients compared to those who did not work face-to-face with 
patients.  
Only socio-economic status did not show a statistically significant relationship with 
receipt of the Panvax vaccine in the univariate analyses (p = 0.45). The odds of 
receiving the Panvax vaccine were not very different between each quintile.  
Table 5. Results from univariate model. 
Covariate Reference level Level Odds 
ratio 
SE (without 
adjusting for 
intracluster 
correlation) 
SE  Lower 
CI 
Upper 
CI 
Overall 
P-value  
Seasonal 
vaccination 
status 
Unvaccinated Vaccinated 6.89 0.46 0.51 5.95 7.97 <0.001 
Years of 
participation 
1 2 1.22 0.06 0.07 1.08 1.37 <0.001 
3 1.56 0.14 0.14 1.30 1.88 
Age (years) 10-19 20-34 2.60 0.36 0.44 1.87 3.62 <0.001 
35-49 3.22 0.42 0.50 2.38 4.36 
50-64 4.39 0.57 0.70 3.21 6.00 
65+ 8.49 1.43 1.70 5.74 12.58 
Working 
face-to-face 
with patients 
No Yes 1.97 0.11 0.11 1.77 2.21 <0.001 
Don’t know 1.42 0.63 0.63 0.59 3.38 
Socio-
economic 
status 
Quintile 1 Quintile 2 0.88 0.10 0.11 0.70 1.11 0.45 
 Quintile 3 0.92 0.09 0.10 0.74 1.14 
 Quintile 4 0.87 0.08 0.09 0.71 1.08 
 Quintile 5 0.83 0.08 0.09 0.68 1.02 
  
From Table 6, after adjusting for age, working with patients status, socio-economic 
status and years of participation in the survey, as well as adjusting for the effect of 
some participants living in the same household and responding for other participants in 
that household, having the seasonal influenza vaccine was still strongly related to 
receiving the Panvax vaccine, with the odds of receiving the Panvax vaccine increasing 
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by 489% for those who received the seasonal vaccine, as compared to those who did 
not.   
The number of years a participant participated in the survey still showed a statistically 
significant relationship (p = 0.02) with uptake of the Panvax vaccine in the multivariate 
model, however this relationship was not as strong as shown in the univariate analysis.  
Age of participants also showed a statistically significant relationship with receiving the 
Panvax vaccine (p<0.001). However, this relationship was not as strong as shown in 
the univariate analysis. For each increase in age group, the odds of receiving the 
Panvax vaccine increased. In particular, the odds of receiving the Panvax vaccine 
increased by 200% for those participants aged 65 years and over compared to those in 
the 10-19 years age group.  
Working face-to-face with patients also showed a statistically significant relationship 
with receiving the Panvax vaccine (p<0.001) in the multivariate model, with the odds of 
receiving the vaccine increasing by 48% for those who worked face-to-face with 
patients compared to those who did not work face-to-face with patients.  
Socio-economic status now showed an even weaker relationship with receipt of the 
Panvax vaccine in the multivariate model (p = 0.82), as compared to the univariate 
model. The odds of receiving the Panvax vaccine were not very different between each 
quintile.  
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Table 6. Results from multivariate model.  
Covariate Reference 
level 
Level Odds 
ratio 
SE (without 
adjusting 
for 
intracluster 
correlation) 
SE  Lower 
CI 
Upper 
CI 
Overall 
P-value 
Seasonal 
vaccination 
status 
Unvaccinated Vaccinated 5.89 0.41 0.45 5.07 6.84 <0.001 
Years of 
participation 
1 2 1.12 0.07 0.07 0.98 1.27 0.02 
3 1.31 0.13 0.13 1.08 1.60 
Age (years) 10-19 20-34 1.24 0.19 0.22 0.87 1.75 <0.001 
35-49 1.30 0.19 0.21 0.95 1.79 
50-64 1.70 0.24 0.28 1.22 2.36 
65+ 3.00 0.54 0.62 2.00 4.51 
Working 
face-to-face 
with patients 
No Yes 1.48 0.09 0.09 1.31 1.67 <0.001 
Don’t know 1.46 0.70 0.69 0.57 3.70 
Socio-
economic 
status 
Quintile 1 Quintile 2 0.92 0.11 0.12 0.72 1.19 0.82 
 Quintile 3 0.95 0.10 0.11 0.75 1.20 
 Quintile 4 0.96 0.10 0.11 0.77 1.20 
 Quintile 5 0.89 0.09 0.10 0.71 1.11 
  
Goodness of fit and testing of model assumptions 
According to the Hosmer-Lemeshow goodness of fit test, the multivariate model 
provided an adequate fit to the data (  ( )               ).  
Pearson and deviance residuals are useful in identifying observations that are not 
explained well by the model20. According to the plot of standardised deviance residuals 
in Figure 3, there do not appear to be any outliers in the data affecting the fit of the 
model (any observations outside a value of +/- 2 or 3 would signal potential outliers 
requiring further investigation). The plot of Pearson residuals also did not reveal any 
potential outliers. Figure 3 also shows that there appears to be a linear relationship 
between the predicted values and the covariates of interest, and constant variance, as 
the plots do not show any obvious trends or curvature. 
Please note that for Figures 3 - 5, each point represents multiple observations.
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Figure 3. Scatter plot of deviance residuals against predicted values for H1N1 from 
final multivariate logistic regression model. 
 
An observation was identified as having high leverage (data points had a large 
influence on the regression results) if it had a leverage value larger than 0.5. Moderate 
leverage was defined as any value between 0.2 and 0.5 (from LMR notes). Figure 4 
shows that no participants had very high leverage.  
Figure 4. Scatter plot of leverage against predicted values for H1N1 from final 
multivariate logistic regression model.  
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Figure 5 shows the Pregibon Delta-Beta influence statistic. This statistic indicates how 
much a regression coefficient would change if an observation was omitted (LMR 
course notes). From Figure 5 there were four points that had much larger Delta-Beta 
values than all other values, requiring further investigation. However, these four points 
in Figure 5 actually represented 653 observations. The largest Delta-Beta value of 2.86 
was shared by 203 observations. These participants had high values for the 
Standardised Pearson residuals, deviance residuals, and leverage values. On further 
investigation, all of these participants participated in the survey for one year, were 
vaccinated with the seasonal influenza vaccine, were aged 49 – 64 years, did not work 
face-to-face with patients, and were in the highest quintile for socio-economic status. 
As these data values were plausible, and there were a large number of participants 
with these same values, it did not warrant further investigation. 
Figure 5. Scatter plot of the Pregibon Delta-Beta influence statistic against predicted 
values for H1N1. 
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Using Kleinbaum, Kuppler, and Mullers (1988) guidelines21, any variable with a VIF 
value over 10 was considered to exhibit a level of multicollinearity to be concerned 
about, and would warrant further investigation. There was no evidence of 
multicollinearity found in the variables included in the model (see Table 7). 
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Table 7. Results from multicollinearity check for each covariate in final logistic 
regression model. 
Covariate Reference level Level VIF value 
Seasonal vaccination status Unvaccinated Vaccinated 1.13 
Years of participation 1 2 1.10 
  3 1.08 
Age (years) 10-19 20-34 2.69 
  35-49 3.75 
  50-64 3.81 
  65+ 1.56 
Working face-to-face with patients No Yes 1.10 
  Don’t know 1.00 
Socio-economic status Quintile 1 Quintile 2 2.06 
  Quintile 3 2.73 
  Quintile 4 2.99 
  Quintile 5 3.20 
No further model fitting was conducted as the model fit was adequate and all model 
assumptions appeared to be satisfied. As only socio-economic status was found to not 
be statistically significant, and this variable was of clinical relevance, it was retained in 
the model.  
Discussion  
The odds of receiving the Panvax vaccine increased by 489% for those who received 
the seasonal vaccine, as compared to those who did not, suggesting a common 
attitude to receipt of both vaccines.  The seasonal influenza vaccine for 2010 contains 
the H1N109 influenza strain. Experts have predicted a return of H1N109 to Australia as 
the dominant strain of influenza during the 2010 influenza season. Therefore, these 
results imply that participants who have not been vaccinated with Panvax, are also 
unlikely to be vaccinated with the seasonal vaccine and, therefore, have no protection 
against a return of H1N109.  
The older a Flutracking participant was, the more likely they were to receive the 
Panvax vaccination. It is now well known that H1N109 affected younger age groups 
more severely than older age groups, and protection against this strain of influenza in 
the young healthy population is therefore crucial. In Australia, the National 
Immunisation Program Schedule22 (current from 1 July 2007) recommends the 
seasonal influenza vaccination for all persons aged 65 years and over.  Therefore, 
persons over the age of 65 years are used to receiving a regular influenza vaccine (and 
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perhaps maybe more trusting of the safety of the vaccine or simply in the routine of 
receiving it). Younger healthy adults may not perceive themselves to be at great risk as 
they are generally healthier and have stronger immune systems than older age groups, 
or perhaps they are less trusting of the safety of the vaccine. These factors suggest 
that changes in attitudes/beliefs of the younger age groups is necessary to ensure 
sufficient uptake for herd immunity against H1N109. 
Participants who worked face-to-face with patients were also more likely to receive the 
Panvax vaccination than those who did not work face-to-face with patients. This finding 
is reassuring, however, 56% of Flutracking participants who work face-to-face with 
patients were not yet vaccinated against H1N109. Barriers to receipt of the vaccine 
should be further explored with this group to ensure the safety of themselves and the 
potentially vulnerable patients they are treating.  
As years of participation in the Flutracking survey increased, participants were more 
likely to receive the Panvax vaccination. This relationship (although statistically 
significant) was one of the weakest relationships in the model. However, this highlights 
an important characteristic of Flutracking participants -  that loyalty of participants to the 
Flutracking survey may be an indicator of support for influenza vaccination.  
Receipt of the Panvax vaccination was similar across each socio-economic status 
quintile. Given that the Panvax vaccination was offered free of charge to all Australians, 
this result is not unexpected.  
The above results help to provide a better understanding of the influences in Australia 
on uptake of the influenza vaccination. This is important as vaccination campaigns are 
still encouraging Australians to receive the Panvax vaccination if they cannot/ choose 
not to receive the seasonal vaccine. Given the likelihood of a return of the H1N109 
strain of influenza in 2010, it is crucial to understand attitudinal barriers and 
demographic differences in likelihood of vaccination. 
There were several limitations identified in this study. Firstly, The Flutracking dataset 
may be viewed as a hierarchical dataset with potentially three levels: person level, 
household level, and geographic level (for example, postcode). Therefore, there may 
be positive correlation between observations from the same household and positive 
correlation between observations from the same postcode. Three approaches can be 
used to adjust for intracluster correlations: 1) fit a marginal model and empirically 
adjusting the standard errors for clustering; 2) apply a multilevel mixed effects logistic 
regression model, fitting a random effect or effects for clustering; or 3) fit a fixed effects 
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model by including the clustering variable or variables as  covariates in the model. In 
the analysis presented, the model included a fixed effect variable for socio-economic 
status and empirically adjusted the standard errors for clustering by household.  The 
socio-economic status variable was created assuming that each individual in a 
postcode had the same level of socio-economic status. It would be preferable to have a 
measure of socio-economic status at the individual level, or alternatively to consider 
postcode as either a fixed or random effect.  
If a multilevel mixed effects model were applied, with a random effect for household 
and a random effect for postcode, then intracluster correlation could be calculated for 
both the household level and geographic level.  Although not reported in the results 
section, a multilevel mixed effects model was fitted to the data. Assumption checking 
showed that the deviance residuals followed a bimodal distribution (rather than a 
normal distribution). The meaning of this result was not understood well enough to be 
confident in the model fit. 
Another limitation with this study was that the results may be subject to missing data 
bias. We assumed that any missing data was random. However, participants who 
stopped completing surveys in October or November may not have had an opportunity 
to respond ‘yes’ to the Panvax vaccination. Alternatively, these participants may be 
less likely to be vaccinated than other participants, as they are less interested in 
influenza. 
A further limitation with this study is that the Flutracking survey was not designed 
specifically for the research question at hand. Therefore, there may be other variables 
influencing the relationships shown in the model that have not been captured in the 
Flutracking data (for example, gender). 
Interactions between covariates were not assessed in this study, as they were not part 
of the research question at hand. This may be an area of interest for future research 
(for example, the interaction between age and seasonal vaccination status, and this 
effect on Panvax vaccination uptake).  
Additional research questions have been identified as a result of the current analysis. 
These include: 1) Assessing factors affecting the uptake of seasonal vaccination in 
Flutracking participants; 2) Assessing factors affecting participant retention Flutracking 
over years of participation; and 3) Assessing whether working face-to-face with patients 
is predictive of influenza-like illness.  
42 
 
References 
                                                          
1. World Health Organisation. What is a pandemic? [cited 9 June 2010]; Available from: 
http://www.who.int/csr/disease/swineflu/frequently_asked_questions/pandemic/en/inde
x.html.  
2. Google Flu Trends. Explore flu trends – Australia [cited 9 June 2010]; Available from: 
http://www.google.org/flutrends/au/#AU.  
3. Department of Health and Ageing. Australian influenza report 2010. Report 18, week 
ending 7 May 2010. [cited 9 June 2010]; Available from: 
http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-ozflu-no18-10.htm.  
4. Bishop JF, Murnane MP, Owen R. Australia’s winter with the 2009 pandemic 
influenza A (H1N1) virus. NEngl J Med 2009: 361( 27): 2591 – 2594. 
5. Department of Health and Ageing. H1N1 influenza latest news: Free pandemic flu 
vaccine available for all. [cited 9 June 2010]; Available from: 
http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/n
ews-300909.  
6. Zheng W, Aitken R, Muscatello DJ, Churches T. Potential for early warning of viral 
influenza activity in the community by monitoring clinical diagnoses of influenza in 
hospital emergency departments. BMC Public Health 2007;7: 250.  
7. Lau EH, Cowling BJ, Ho LM, Leung GM. Optimizing use of multistream influenza 
sentinel surveillance data. Emerg Infect Dis 2008 Jul [Online] [cited 21 October 2008]; 
Available from: http://www.cdc.gov/EID/content/14/7/1154.htm.  
8. Carlson SJ, Dalton CB, Tuyl FA, Durrheim DN, Fejsa J, Muscatello DJ, et al. 
Flutracking surveillance: Comparing 2007 New South Wales results with laboratory 
confirmed influenza notifications. Commun Dis Intell 2009;33(3): 323–326. 
9. Dalton C, Durrheim D, Fejsa J, Francis L, Carlson S, Tursan d'Espaignet E, et al. 
Flutracking: A weekly Australian community online survey of influenza-like illness in 
2006, 2007 and 2008. Commun Dis Intell 2009;33(3):316–322. 
10. NSW Department of Health. Notifiable Diseases Database (HOIST), Centre for 
Epidemiology and Research.  
11. Pankratz A. Forecasting with dynamic regression models. New York: John Wiley & 
Sons Inc; 1991.  
12. Schwartz J, Spix C, Touloumi G, Bachárová L, Barumamdzadeh T, le Tertre A, et 
al. Methodological issues in studies of air pollution and daily counts of death or hospital 
admissions. J Epidemiol Community Health 1996;50 (Suppl 1): S3–S11.  
43 
 
                                                                                                                                                                          
13. Box GEP, Jenkins GM, Reinsal GC. Time series analysis: Forecasting and control. 
New Jersey: Prentice Hall; 1994.  
14. Fisher LD, van Belle G. Biostatistics: A methodology for the health sciences. New 
York: John Wiley & Sons Inc; 1993.  
15. SAS 9.1.3 Help and Documentation. Cary (USA): SAS Institute; 2002–2004. 
16. Department of Health and Ageing. H1N1 influenza latest news: Pandemic flu 
vaccine approved for children. [cited 9 June 2010]; Available from: 
http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/n
ews-0322009.  
17. Australian Bureau of Statistics. 2033.0.55.001 - Census of Population and Housing: 
Socio-Economic Indexes for Areas (SEIFA), Australia - Data only, 2006. [cited 9 June 
2010]; Available from: 
http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/2033.0.55.0012006?OpenD
ocument.  
18. Graubard BI, Korn, EL. Regression analysis with clustered data. Statistics in 
Medicine. 1994: 13: 509-522. 
19. Bewick V, Cheek L, Ball, J. Statistics review 14: Logistic regression. Critical Care. 
2005: 9(1): 112-118. 
20. SAS/STAT® 9.2 User’s Guide, Second Edition. [cited 25 June 2010]; Available 
from 
http://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/viewer.htm#/d
ocumentation/cdl/en/statug/63033/HTML/default/statug_logistic_sect042.htm.  
21. Kleinbaum D.G, Kupper L.L, Muller K.E, Applied regression analysis and other 
multivariate methods (2nd edition), PWS-KENT Publishing, 1988. Pp 206-217. 
22. Department of Health and Ageing. National immunisation program schedule. [cited 
28 June 2010]; Available from 
http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/nips2.  
